Why this status
- 24 Jun 2026: Trial registered, NCT07666698
- 1 Jul 2026: Trial started, NCT07666698
The trials
NCT07666698: A Study of Metformin to Improve Cardiac Function After LVAD Implantation
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 108 planned
- Started
- 1 Jul 2026
- Primary completion
- Jul 2028
- Arms
- Metformin Group
- Results
- None posted
- 24 Jun 2026: Trial registered
- 1 Jul 2026: Trial started
How the status changed
- 19 Nov 2026: First set: Phase 1 trial
About the treatment
Kind of treatment: Drug.
Also known as Apophage, Benofomin, Diabefagos, Diabex, Extended Release Metformin Hydrochloride, Fortamet, Glucaminol, Glucophage, Glucophage xr, Glucovance component metformin hydrochloride, Glumetza, Invokamet component metformin hydrochloride, Janumet component metformin hydrochloride, Kazano component metformin hydrochloride, Metformin XR, Metformin hydrochloride (HCl) 500mg tablet, Neodipa, Qternmet component metformin hydrochloride, Qternmet xr component metformin hydrochloride, Riomet, Riomet er, Segluromet component metformin hydrochloride, Siamformet, Trijardy xr component metformin hydrochloride, Walaphage, Xigduo component metformin hydrochloride, Zituvimet component metformin hydrochloride.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.